The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SIMRISE: A randomized phase III trial evaluating SIM0270 in combination with everolimus versus treatment of physician’s choice in patients with ER+/HER2- advanced breast cancer, previously treated with CDK4/6 inhibitors.
 
Jiong Wu
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Yongmei Yin
No Relationships to Disclose
 
Yehui Shi
No Relationships to Disclose
 
Xinhong Wu
No Relationships to Disclose
 
Tao Sun
No Relationships to Disclose
 
Chen Yang
Employment - State Key Laboratory of Neurology and Oncology Drug Development,Simcere Zaiming Pharmaceutical Co., Ltd
 
Lili Zhu
Employment - State Key Laboratory of Neurology and Oncology Drug Development,Simcere Zaiming Pharmaceutical Co., Ltd
 
Ya Li
Employment - State Key Laboratory of Neurology and Oncology Drug Development,Simcere Zaiming Pharmaceutical Co., Ltd
 
Chunyan He
Employment - State Key Laboratory of Neurology and Oncology Drug Development,Simcere Zaiming Pharmaceutical Co., Ltd